Somnum Pharma, Inc.
New York, US · Founded 2024 · New York corporation · 1 known investors
Founders & leadership
Board
MJ
Michael JasulavicBoard director
OD
Orrin DevinskyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2024
▶$2MraisedNov 2024 · PharmaceuticalsRule 506(b)
▶$2MraisedNov 2024 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael JasulavicDirector
- Orrin DevinskyDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $800K
- First sale
- Nov 2024
- Incorporated
- Corporation, New York, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Somnum Pharma, Inc.'s investors?
- Somnum Pharma, Inc.'s investors include PhiFund2.
- How much funding has Somnum Pharma, Inc. raised?
- Somnum Pharma, Inc. has disclosed $2M raised across 1 round.
- Where is Somnum Pharma, Inc. headquartered?
- Somnum Pharma, Inc. is headquartered in New York, US.